Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Julianne Bayliss, Michael Nissen, Damita Prakash, Peter Richmond, Kyu-Bin Oh & Terry Nolan. (2021) Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine. Human Vaccines & Immunotherapeutics 17:1, pages 176-190.
Read now
Read now
Ivonne Puente Gómez, Céline Verheust, Linda Hanssens & Jan Dolhain. (2020) Safety profile of Infanrix hexa – 17 years of GSK’s passive post-marketing surveillance. Expert Review of Vaccines 19:8, pages 771-779.
Read now
Read now
Pablo Obando-Pacheco, Irene Rivero-Calle, Peter Francis Raguindin & Federico Martinón-Torres. (2019) DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age. Expert Review of Vaccines 18:11, pages 1115-1126.
Read now
Read now
Shabir A. Madhi, Pío López, Betzana Zambrano, Emilia Jordanov, Siham B’Chir, Fernando Noriega & Emmanuel Feroldi. (2019) Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration. Human Vaccines & Immunotherapeutics 15:3, pages 658-668.
Read now
Read now
Pope Kosalaraksa, Kulkanya Chokephaibulkit, Suwat Benjaponpitak, Chitsanu Pancharoen, Sunate Chuenkitmongkol, Siham B'Chir, Xavier Da Costa & Emmanuel Vidor. (2018) Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months. Human Vaccines & Immunotherapeutics 14:5, pages 1257-1265.
Read now
Read now
Dang Duc Anh, Olivier Van Der Meeren, Naveen Karkada, Deepak Assudani, Ta-Wen Yu & Htay Htay Han. (2016) Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study. Human Vaccines & Immunotherapeutics 12:3, pages 655-657.
Read now
Read now
Articles from other publishers (15)
Claire Alexander, Mariel Cabrera, Michael Moore & Marta Lomazzi. (2023) Driving Paediatric Vaccine Recovery in Europe. Vaccines 11:1, pages 184.
Crossref
Crossref
Matthew Rajan, Natalie Marchevsky, Gemma Sinclair, Katie O’Brien, Kimberley Jefferies, Nelly Owino, Bassam Hallis, David Goldblatt, Mary Matheson, Hannah Cuthbertson, Parvinder Aley, Xinxue Liu & Matthew D. Snape. (2022) A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal Vaccine. Pediatric Infectious Disease Journal 42:1, pages 66-73.
Crossref
Crossref
Michael D. Decker, Barbara J. Howe, David P. Greenberg & Kathryn M. Edwards. 2023. Plotkin's Vaccines. Plotkin's Vaccines
225
247.e13
.
Markus Knuf, Hervé Haas, Pilar Garcia-Corbeira, Elisa Turriani, Piyali Mukherjee, Winnie Janssens & Valérie Berlaimont. (2021) Hexavalent vaccines: What can we learn from head-to-head studies?. Vaccine 39:41, pages 6025-6036.
Crossref
Crossref
Silvia Ricci, Clementina Canessa, Lorenzo Lodi, Mattia Giovannini, Francesca Lippi, Maria Moriondo, Francesco Nieddu & Chiara Azzari. (2020) Invasive Haemophilus influenzae Type b Disease in the Post Hexavalent Era. Pediatric Infectious Disease Journal 39:4, pages 294-297.
Crossref
Crossref
Pablo Obando-Pacheco, Irene Rivero-Calle, José Gómez-Rial, Carmen Rodríguez-Tenreiro Sánchez & Federico Martinón-Torres. (2018) New perspectives for hexavalent vaccines. Vaccine 36:36, pages 5485-5494.
Crossref
Crossref
Jose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, Xavier Maria Perez Porcuna, Maria del Carmen Otero Reigada, Josep Marès Bermúdez, Fernando Centeno Malfaz, Mariano Miranda, Maria Mendez, Miguel Angel Garcia Cabezas, Wittermann Christoph, Gerhard Bleckmann, Thomas Fischbach, Devayani Kolhe, Marie Van der Wielen & Yaela Baine. (2018) Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants. Pediatric Infectious Disease Journal 37:7, pages 704-714.
Crossref
Crossref
Susana Monge, Susan JM Hahné, Hester E de Melker, Elisabeth AM Sanders, Arie van der Ende & Mirjam J Knol. (2018) Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003–16): a case-control study. The Lancet Infectious Diseases 18:7, pages 749-757.
Crossref
Crossref
Lalitendu Mohanty, Sunil Sharma, Beauty Behera, Sachin Panwar, Charu Paliwal, Anu Gupta, Deepak Chandra Chilkoti & Anit Singh. (2018) A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants. Vaccine 36:17, pages 2378-2384.
Crossref
Crossref
Michael D. Decker, Kathryn M. Edwards & Barbara J. Howe. 2018. Plotkin's Vaccines. Plotkin's Vaccines
198
227.e13
.
Domenico Martinelli, Chiara Azzari, Paolo Bonanni, Susanna Esposito, Elisabetta Franco, Giancarlo Icardi, Gianvincenzo Zuccotti & Rosa Prato. (2017) Impact of Haemophilus influenzae type b conjugate vaccination on hospitalization for invasive disease in children fifteen years after its introduction in Italy. Vaccine 35:46, pages 6297-6301.
Crossref
Crossref
Adi Essam Zarei, Hussein A. Almehdar & Elrashdy M. Redwan. (2016) Hib Vaccines: Past, Present, and Future Perspectives. Journal of Immunology Research 2016, pages 1-18.
Crossref
Crossref
Gasim I Gasim, Abdelhaleem Bella & Ishag Adam. (2015) Schistosomiasis, hepatitis B and hepatitis C co-infection. Virology Journal 12:1.
Crossref
Crossref
R. Orlando, M. Foggia, A. E. Maraolo, S. Mascolo, G. Palmiero, O. Tambaro & G. Tosone. (2015) Prevention of hepatitis B virus infection: from the past to the future. European Journal of Clinical Microbiology & Infectious Diseases 34:6, pages 1059-1070.
Crossref
Crossref
Papaevangelou Vassiliki, Koutsoumbari Ioanna, Vintila Artemis, Klinaki Eleni, Zellos Aglaia, Achilleas Attilakos, Tsolia Maria & Kafetzis Dimitris. (2014) Determinants of vaccination coverage and adherence to the Greek national immunization program among infants aged 2-24 months at the beginning of the economic crisis (2009-2011). BMC Public Health 14:1.
Crossref
Crossref